2,2-bis(3-chloro-4-hydroxyphenyl)propane: has estrogenic activity; structure in first source
ID Source | ID |
---|---|
PubMed CID | 66238 |
SCHEMBL ID | 37041 |
MeSH ID | M0482150 |
Synonym |
---|
ENAMINE_005935 |
3,3'-dichlorodian |
nsc18247 |
4,4'-isopropylidenebis[2-chlorophenol] |
2,2-bis(4-hydroxy-3-chlorophenyl)propane |
79-98-1 |
phenol,4'-isopropylidenebis[2-chloro- |
nsc-18247 |
3,3'-dichlorobisphenol a |
phenol,4'-(1-methylethylidene)bis[2-chloro- |
2,2-bis(3-chloro-4-hydroxyphenyl)propane |
OPREA1_815250 |
nsc 18247 |
einecs 201-241-6 |
4,4'-isopropylidenebis(2-chlorophenol) |
4,4'-isopropylidenebis(o-chlorophenol) |
phenol, 4,4'-(1-methylethylidene)bis(2-chloro- |
phenol, 4,4'-isopropylidenebis(2-chloro- |
IDI1_008170 |
HMS1410N17 |
2-chloro-4-[2-(3-chloro-4-hydroxyphenyl)propan-2-yl]phenol |
FT-0666557 |
unii-ws963ra8kz |
ws963ra8kz , |
4,4'-(1-methylethylidene)bis[2-chlorophenol] |
2,2-di(4-hydroxy-3-chlorophenyl)propane |
phenol, 4,4'-(1-methylethylidene)bis[2-chloro- |
SCHEMBL37041 |
2,2-bis(3-chloro,-4-hydroxyphenyl)propane |
2,2-bis-(4-hydroxy-3-chlorphenyl)-propane |
DTXSID3058826 |
4,4'-isopropylidenebis[o-chlorophenol] |
4,4'-isopropylidene-bis(2-chlorophenol) |
sr-01000596913 |
SR-01000596913-1 |
2,2'-dichloro bisphenol a |
AS-6196 |
4,4'-(propane-2,2-diyl)bis(2-chlorophenol) |
2,2-bis(3-chloro-4-hydroxyphenyl) propane |
AKOS037645642 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.91) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |